Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/PHAXIAM-THERAPEUTICS-S-A-159356796/news/PHAXIAM-Therapeutics-Announces-Enrolment-of-First-Patient-in-the-Phase-1-Study-for-the-Treatment-of-46443165/?utm_source=whatsapp&utm_medium=social&utm_campaign=share